Innovator Intl Developed Power Buffer ETF
$36.00-$0.15 (-0.41%)
Innovator Intl Developed Power Buffer ETF’s quoted price sits in the upper half of its reported 52-week range, 7.64% below the high.
AMEX · PILL · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Direxion Daily Pharmaceutical & Medical Bull 3X ETF’s quoted price sits in the lower half of its reported 52-week range, 37.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Direxion Daily Pharmaceutical & Medical Bull 3X ETF’s forward annual dividend is $0.00 per share, paid quarterly. The forward yield is 0.02% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
PILL seeks to deliver investment results of 3x the daily performance of the S&P Pharmaceuticals Select Industry Index, a modified equal-weighted index that measures the performance of pharmaceutical companies, as defined by GICS, on the S&P Total Market Index. The fund uses derivatives and swaps to achieve its target exposure. As a levered product with daily resets, PILL is designed as a short-term trading tool and not a long-term investment vehicle. As a result, long-term returns could materially differ from those of the underlying index due to daily compounding. Prior to August 2, 2019, the fund aimed to provide 3x leveraged exposure to the Dynamic Pharmaceutical Intellidex Index. Effective February 27, 2026, the fund replaced the term Shares in its name with ETF.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$36.00-$0.15 (-0.41%)
Innovator Intl Developed Power Buffer ETF’s quoted price sits in the upper half of its reported 52-week range, 7.64% below the high.
$30.92-$0.52 (-1.65%)
Roundhill Investments - S&P 500 No Dividend Target ETF’s quoted price sits in the upper half of its reported 52-week range, 3.31% below the high.
$11.52-$0.09 (-0.77%)
Indexperts Quality Earnings Focused ETF’s quoted price sits in the upper half of its reported 52-week range, 4.36% below the high.
$35.43-$0.48 (-1.35%)
TrueShares Structured Outcome (June) ETF’s quoted price sits in the upper half of its reported 52-week range, 2.34% below the high.
$92.63-$1.46 (-1.55%)
Invesco S&P SmallCap Materials ETF’s quoted price sits in the upper half of its reported 52-week range, 15.81% below the high.
$33.03-$0.59 (-1.74%)
KraneShares Man Buyout Beta Index ETF’s quoted price sits in the upper half of its reported 52-week range, 4.35% below the high.
$28.38-$1.10 (-3.75%)
Adaptive Core ETF’s quoted price sits in the upper half of its reported 52-week range, 17.56% below the high.
$45.44+$0.12 (+0.27%)
ProShares - Merger ETF’s quoted price sits in the upper half of its reported 52-week range, 1.7% below the high.